HLB Genex, Inc. (KOSDAQ:187420)
South Korea · Delayed Price · Currency is KRW 1,886.00
+10.00 (0.53%)
At close: Aug 24, 2026
HLB Genex Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 61,568 | 77,210 | 129,724 | 88,872 | 122,761 | 183,817 | |
Market Cap Growth | -31.39% | -40.48% | 45.97% | -27.61% | -33.22% | -25.40% |
Enterprise Value | 82,170 | 89,239 | 165,977 | 139,915 | 163,614 | 217,915 |
Last Close Price | 1886.00 | 2650.00 | 4460.00 | 3905.00 | 5450.00 | 8170.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.07 | 3.42 | - | - | - | - |
Forward PE | - | 83.60 | 83.60 | 83.60 | 83.60 | 83.60 |
PS Ratio | 1.35 | 1.78 | 3.66 | 3.29 | 4.42 | 7.10 |
PB Ratio | 0.90 | 1.41 | 4.60 | 3.02 | 3.81 | 4.74 |
P/TBV Ratio | 1.60 | 2.99 | 5.77 | 4.31 | 5.46 | 5.39 |
P/FCF Ratio | 17.38 | 28.79 | 58.40 | - | - | - |
P/OCF Ratio | 12.51 | 22.04 | 45.20 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.80 | 2.06 | 4.68 | 5.18 | 5.89 | 8.42 |
EV/EBITDA Ratio | 18.01 | 15.53 | 62.86 | - | - | - |
EV/EBIT Ratio | - | 69.95 | - | - | - | - |
EV/FCF Ratio | 23.19 | 33.28 | 74.72 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.61 | 0.80 | 1.58 | 2.12 | 2.44 | 1.52 |
Debt / EBITDA Ratio | 7.75 | 7.57 | 16.88 | - | - | - |
Debt / FCF Ratio | 11.80 | 16.23 | 20.07 | - | - | - |
Net Debt / Equity Ratio | 0.09 | 0.18 | -1.39 | 1.10 | 1.15 | 0.86 |
Net Debt / EBITDA Ratio | 1.12 | 1.75 | -14.86 | -6.73 | -20.81 | -348.70 |
Net Debt / FCF Ratio | 1.70 | 3.75 | -17.66 | -5.39 | -4.25 | -3.00 |
Asset Turnover | 0.33 | 0.31 | 0.29 | 0.23 | 0.22 | 0.22 |
Inventory Turnover | 4.01 | 4.39 | 3.72 | 3.57 | 3.38 | 3.49 |
Quick Ratio | 0.90 | 0.66 | 1.00 | 0.64 | 0.56 | 0.61 |
Current Ratio | 1.08 | 0.80 | 1.07 | 0.75 | 0.63 | 0.72 |
Return on Equity (ROE) | 16.75% | 55.20% | -62.19% | -2.34% | -37.67% | -20.36% |
Return on Assets (ROA) | 0.48% | 0.56% | -0.95% | -5.10% | -3.08% | -2.07% |
Return on Invested Capital (ROIC) | 1.37% | 4.54% | -7.25% | -14.42% | -8.80% | -5.63% |
Return on Capital Employed (ROCE) | 1.20% | 1.70% | -3.30% | -23.30% | -13.80% | -5.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 15.05% | 29.26% | -14.51% | -3.32% | -10.56% | -3.71% |
FCF Yield | 5.75% | 3.47% | 1.71% | -6.78% | -7.11% | -6.04% |
Buyback Yield / Dilution | -62.65% | -105.88% | -4.10% | -0.44% | -0.30% | -2.01% |